(19)
(11) EP 0 984 947 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
15.06.2005 Bulletin 2005/24

(45) Mention of the grant of the patent:
20.04.2005 Bulletin 2005/16

(21) Application number: 98922303.7

(22) Date of filing: 18.05.1998
(51) International Patent Classification (IPC)7: C07D 263/20, C07D 417/12, C07D 413/10, C07D 413/04, A61K 31/42, C07D 261/04, C07D 307/32, C07D 471/10
// (C07D471/10, 235:00), C07D221:00
(86) International application number:
PCT/US1998/009889
(87) International publication number:
WO 1998/054161 (03.12.1998 Gazette 1998/48)

(54)

OXAZOLIDINONE ANTIBACTERIAL AGENTS HAVING A THIOCARBONYL FUNCTIONALITY

ANTIBAKTERIELL WIRKSAM OXAZOLIDINONE MIT EINER THIOCARBONYLFUNKTIONALITÄT

AGENTS ANTIBACTERIENS OXAZOLIDINONE AYANT UNE FONCTIONNALITE THIOCARBONYLE

(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 30.05.1997 US 48342 P

(43) Date of publication of application:
15.03.2000 Bulletin 2000/11

(73) Proprietor: Pharmacia & Upjohn Company LLC
Kalamazoo, MI 49001 (US)

(72) Inventors:
  • HESTER, Jackson, B., Jr.
    Galesburg, MI 49053 (US)
  • NIDY, Eldon, George
    Kalamazoo, MI 49001 (US)
  • PERRICONE, Salvatore, Charles
    Delton, MI 49046 (US)
  • POEL, Toni-Jo
    Wayland, MI 49348 (US)

(74) Representative: Perry, Robert Edward 
GILL JENNINGS & EVERY Broadgate House 7 Eldon Street
London EC2M 7LH
London EC2M 7LH (GB)


(56) References cited: : 
EP-A- 0 127 902
EP-A- 0 359 418
WO-A-95/07271
WO-A-98/07708
 EP-A- 0 184 170
EP-A- 0 789 025
WO-A-97/14690
DE-A- 19 601 264
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).